The effect of exercise on disease-free survival and overall survival in patients with breast cancer

Basit Öğe Kaydı
dc.contributor.authorAkdeniz, Nadiye
dc.contributor.authorKaplan, Muhammet Ali
dc.contributor.authorKucukoner, Mehmet
dc.contributor.authorUrakci, Zuhat
dc.contributor.authorLacin, Sahin
dc.contributor.authorCeylan, Emre Husnu
dc.contributor.authorIsikdogan, Abdurrahman
dc.date.accessioned2024-04-24T16:02:35Z
dc.date.available2024-04-24T16:02:35Z
dc.date.issued2022
dc.departmentDicle Üniversitesien_US
dc.description.abstractBackground Positive effects of exercise in cancer patients have been reported. Aim To investigate whether intensity, duration, and timing of exercise affect disease relapse and mortality risk in patients with breast cancer (BC). Methods Patients with local or locally advanced stages of BC between January 2018 and January 2020 were recruited in the study. Sociodemographic and clinicopathological characteristics of patients were recorded. Exercise evaluation was performed by preparing a questionnaire and asking the patients face-to-face questions in the outpatient clinic. Results Risk of relapse was 58% lower in patients who exercised than inactive patients (p = 0.004). Patients who exercised for 2 to 5 days per week had a 63% lower relapse risk than inactive patients (p = 0.010). Risk of relapse was 66% lower in the patients who exercised for less than 1 h or 3 metabolic equivalent of task (MET)-hours per week when compared to inactive patients (p = 0.037). Similarly, relapse risk was 62% lower in patients who exercised between 1 to 3 h or 3 to 8.9 MET-hours per week than inactive patients (p = 0.026). Mortality risk was lower in patients who exercised than patients who did not (p = 0.027). A significantly decreased mortality risk was found in both groups that included patients who exercised for 1 to 5 days per week and patients who exercised for less than 3 h or 9 MET-hours per week when compared to inactive patients. Conclusion Exercise was associated with decreased relapse and mortality rates in patients with BC. Therefore, exercise should be recommended to BC patients as a significant component of the treatment.en_US
dc.identifier.doi10.1007/s11845-021-02785-y
dc.identifier.endpage1597en_US
dc.identifier.issn0021-1265
dc.identifier.issn1863-4362
dc.identifier.issue4en_US
dc.identifier.pmid34606055
dc.identifier.scopus2-s2.0-85116329290
dc.identifier.scopusqualityQ1
dc.identifier.startpage1587en_US
dc.identifier.urihttps://doi.org/10.1007/s11845-021-02785-y
dc.identifier.urihttps://hdl.handle.net/11468/14845
dc.identifier.volume191en_US
dc.identifier.wosWOS:000703624800001
dc.identifier.wosqualityQ3
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.language.isoenen_US
dc.publisherSpringer London Ltden_US
dc.relation.ispartofIrish Journal of Medical Science
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectBreast Canceren_US
dc.subjectExerciseen_US
dc.subjectMortalityen_US
dc.subjectRelapseen_US
dc.subjectSurvivalen_US
dc.titleThe effect of exercise on disease-free survival and overall survival in patients with breast canceren_US
dc.titleThe effect of exercise on disease-free survival and overall survival in patients with breast cancer
dc.typeArticleen_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayın Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu